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Introduction
Breast cancer is the most commonly diagnosed cancer 
in women with significant cancer related mortality in the 
developed and developing countries (Yusuf et al., 2013)
Patients with unilateral breast cancer have an added 
risk of cancer in the contra lateral breast with prevalence 
of 1-4% (Jobsen et al., 2003). These patients have a 
higher rate of distant metastasis and unfavorable disease 
specific survival as compared to those with unilateral 
breast tumour (Heron et al., 2000). It is important to 
diagnose contra lateral breast cancer at the time of 
initial diagnosis as the actuarial survival rates at 5 years 
is lower for patients with bilateral synchronous breast 
cancer (64.4%) as compared to patients with unilateral 
disease (75.8%). (Polednak et al., 2003). Screening 
mammography has resulted in early diagnosis of breast 
cancer which has led to more conservative surgical 
approach. Since undetected malignant foci frequently 
results in relapses after breast conservative surgery as 
reported in 3-19% of patients, (Goethem et al., 2004) this 
surgical option should be utilized after the exclusion of 
undetected multifocal /multicenteric disease in addition 
to any contralateral synchronous cancer (Esserman et 
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Abstract
 Aims: The purpose of our study was to evaluate the diagnostic performance of breast magnetic resonance 
imaging (MRI) in the evaluation of contralateral breast in patients with diagnosed breast cancer. A secondary 
objective was to determine accuracy of breast MRI in diagnosing multi-focal and multicentric lesions in the 
ipsilateral breast. Materials and Methods: Using a non-probability convenience sampling technique, patients 
with histopathologically diagnosed breast cancer with MRI of breast performed to exclude additional lesions were 
included. MRI findings were correlated with histopathology. In addition, follow-up imaging with mammography 
and ultrasound was also assessed for establishing stability of negative findings and for the detected of benign 
lesions. Results: Out of 157 MRI breast conducted during the period of 2008 to 2013, 49 were performed for 
patients with diagnosed breast cancer. The sample comprised of all females with mean age 50.7±11.0 years. The 
patient follow-up imaging was available for a period of 2-5 years. The sensitivity, specificity, and positive and 
negative predictive values of MRI in the detection of multifocal/multicenteric lesions was 85.7%, 88.8%, 60% 
and 96.6% respectively and for the detection of lesions in the contralateral breast were 100%, 97%, 83.3% and 
100% respectively. Conclusions: Our study highlights the diagnostic performance and the added value of MRI 
in the detection of multifocal /multicenteric and contralateral malignant lesions. In patients with diagnosed 
breast cancer having dense breast parenchyma and with infiltrating lobular carcinoma as the index lesion MRI 
is particularly useful with excellent negative predictive value in the exclusion of additional malignant foci in the 
ipsilateral and contralateral breasts. 
Keywords: MRI breast - multicenteric - multifocal - bilateral breast cancer
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al., 1999). The sensitivity of screening mammography 
is reduced in women with heterogeneously dense /dense 
breast parenchyma but whole breast ultrasounds is useful 
in the detection of mammographically and clinically occult 
ipsilateral and contra lateral breast cancer (Moon ,2002; 
Beysebayev, 2014) with reasonably accurate estimation of 
invasive cancer but often underestimates the component 
of ductal carcinoma in situ. (DCIS) (Satake et al., 2000). 
Breast Magnetic resonance imaging (MRI) has 
emerged as an important adjunctive tool and multiple 
studies have shown increased detection of tumor foci 
not identified on mammography or ultrasound. Multiple 
diagnostic and screening indications for MRI breast 
have been discussed and suggested by American college 
of radiology (ACR 2013) An additional occult cancer 
in contralateral breast detected on MRI ranges from 
3-24% and this subsequently alters the management plan 
(Liberman, 2003; Kowalchik, 2012).
The purpose of our study was to evaluate the diagnostic 
performance of breast MRI in the evaluation of contra 
lateral breast in patients with diagnosed breast cancer. 
The secondary objective was to evaluate accuracy of 
breast MRI in diagnosing multi focal and multicenteric 
lesions in the ipsilateral breast. 
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Materials and Methods
This cross sectional analytical study was conducted 
in the Radiology department AKUH after obtaining 
exemption (2862-Rad-ERC-13) from the hospital ethical 
review committee.
All MRI breast done during the period of January 2008 
to December 2013 were included. Using non-probability 
convenience sampling technique, all of the patents with 
histopathologically diagnosed breast cancer and with MRI 
of breast done to exclude additional lesions were included. 
These patients had no clinical, mammographic or breast 
ultrasound evidence of occult additional breast lesions. 
Patients were excluded if the MRI breast was done for 
other indications like for assessment of BIRADS 3 lesions, 
implant evaluations, screening, neoadjuvant response 
evaluation, differentiation of scar versus recurrence. 
Patients were also excluded if no follow-up imaging was 
available.
Patient’s mammography and ultrasound done at the 
time of breast cancer diagnosis were also assessed. The 
index lesion was defined as the first lesion detected by 
patient as palpable lump or first detected at imaging or 
the lesion assigned as highest BIRADS category when 
more than one lesions were detected at initial workup. 
(Kim et al., 2014). The MRI findings were correlated 
with histopathology. In addition follow-up imaging i.e. 
mammography and ultrasound were also assessed for 
establishing stability of negative findings and for the 
detected benign lesions. For the purpose of reporting and 
data analysis, the multi focal and multicenteric cancers 
were taken as one group, For the study breast cancer on 
contralateral side was defined as cancer diagnosed in both 
breast concurrently or within a period of three months of 
diagnosis of the first lesion (Jobsen et al., 2003). 
Statistical analysis plan 
Data was entered and analyzed in SPSS 20.0 version. 
The data comprised of age of the patient, mammographic 
density, prior mammography and ultrasound findings, 
the breast involved, histopathology of index lesions 
and the MRI detected lesions in the ipsilateral breast 
i.e. multifocal/multicenteric lesions and in contralateral 
breast. In addition development of malignancy on follow 
up imaging was also noted. Means and Standard deviation 
were computed for quantitative variable like age and 
proportions reported for qualitative variable. Sensitivity, 
specificity, positive and negative predictive values with 
95%confidence interval were computed for MRI breast 
in the evaluation of contra lateral and ipsilateral breast in 
patients with diagnosed breast cancer. Diagnostic accuracy 
of breast MRI was also calculated. 
Reported sensitivity of breast MRI for the detection 
of breast carcinoma is 92% (Hillman et al., 2012) with 
confidence interval of 95%, bound on error of 8%, the 
calculated sample size was N=45. 
Breast MRI technique
All cases underwent a breast MRI in a 1.5 tesla unit. 
The conventional departmental breast MRI protocol was 
carried out using breast coil with patient in prone position. 
The field of view was 300-340 mm and slice thickness 
of 4 mm. 
Prior to post contrast images axial TRIM, T1 and T2 
weighted images were obtained. In addition diffusion 
weighted images and sagittal T2 fat saturated images 
also obtained. This is followed by dynamic post contrast 
images in the axial plane. Vascular access obtained with 
a cannula for the administration of Gadolinium using 
power injector at a dose of 0.1 mmol/kg of body weight 
followed by 20 ml of saline flush. The dynamic image 
sequence was repeated six times with 30 sec interval and 
the images were obtained in the axial plane. The delayed 
post contrast image were obtained in coronal sections. Post 
processing included subtracted images, 2D and 3D MIP 
(maximum intensity projection) reconstructions, wash in 
and washout maps and kinetic curve analysis.
The images were interpreted by radiologist with 
more than 5 years’ experience in breast imaging on soft 
copy using picture archiving and communication system 
(PACS) with provision of manual window setting and 
parameters optimization. The radiologist was provided 
with patient clinical history and all available imaging like 
mammograms and ultrasound of breast. The breast lesion 
was categorized using Breast imaging reporting and data 
system (BIRADS) MR Lexicon. 
The MRI detected lesions were classified in accordance 
to that described in literature (Liberman et al., 2002) 
based on T2 signal intensity, mass or non-mass like 
enhancement, features of a mass like margins, shape, 
enhancement and kinetic curve analysis 
For all MRI detected suspicious findings second look 
sonography was performed to determine if a correlate 
of the lesion is evident and to assess for feasibility of 
ultrasound guided biopsy. The mammograms were 
also reviewed to assess for presence of mammographic 
correlate. 
Patients follow up imaging ie mammography and 
ultrasound were reviewed and any suspicious finding 
recorded.
The mastectomy/ lumpectomy specimen was grossed 
according to the standard criteria and representative 
sections were submitted, five micron sections were cut 
from paraffin embedded tissue blocks and were stained 
with hematoxylin and eosin. The microscopic findings 
were noted and reported by an experienced pathologist. 
Where the need arise, immunohistochemical stains were 
also performed. Reporting was done on a synoptic pattern 
according to the College of American pathologist (CAP) 
guidelines. 
Results 
Out of the 157 MRI breast done during the period 
of 2008 to 2013, 49 were performed in patients with 
diagnosed breast cancer. Four patients were post 
unilateral mastectomy (duration post-surgery being 1 to 
3 months) and MRI studies were done for the evaluation 
of contralateral breast only. 
The sample comprised of all female with mean age 
50.7 +/-11.04 years. Age range was 46 years and minimum 
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and maximum were 26 and 71 years respectively. The 
patient follow-up imaging was available for a period of 
2 to 5 years. 
Second look ultrasound performed to evaluate the 21 
MRI detected suspicious findings in the ipsilateral (n=11) 
and contralateral (n=10) breast. Ultrasound correlate was 
identified for suspicious lesions presenting with mass like 
enhancement in 13 (62%). Abnormal foci of enhancement 
without an associated mass and measuring less than 5 mm 
noted in 8 cases showed no corresponding sonographic 
correlate and these patients on follow-up imaging were 
stable without any interval development. 
Due to the nonexistence of a national screening 
programme in our country the indication for initial 
imaging in 69% of patients was palpable breast lump, 
pain in 8%, and nipple discharge in 2%. In 20% of patients 
the reason for initial imaging was as a part of general 
medical checkup. The breast density on mammography 
was heterogeneously dense in 45%, fibro glandular in 
31% and dense in 20%.The breast parenchyma was fatty 
on mammography in only 4%. 
The size of the index lesion at the time of presentation 
was from 1 to 2cm in 43% (n=21) followed by 2 to 5 cm 
in 35 %(n=17). Less than 1cm index lesions were seen 
in 14%. The size of the index lesion was more than 5 cm 
in 8%. 
The predominant histopathology of the primary / 
Figure 1. Dynamic Post Contrast Enhanced MRI 
Showing Index Lesion in Right Breast with Multiple 
Enhancing Foci Suggestive of Multifocal /Multicenteric 
and Bilateral Disease. On second look ultrasound a well-
defined hypo echoic lesion correlated with the right breast 
nodular enhancing lesion which on biopsy diagnosed as 
fibroadenoma. No correlate seen on second look ultrasound for 
the contralateral breast. No suspicious finding in left breast on 
follow up imaging
Figure 2. Right Breast Multifocal Multicenteric Disease 
(Arrows) on Dynamic Contrast Enhanced Scan. An 
ultrasound correlate was detected for these lesions , which on 
biopsy confirmed presence of multifocality /multicentericity
Table 2. Table 2 : Comparison of previous studies for assessment of multifocal / multicentric & contralateral 
malignant lesions by Breast MRI
Author Publication Year Sample Size Multifocal Multicentric lesions
Contralateral le-
sions
Liberman et al 2003 70 20% 4% 5.0%
Berg et al 2004 120 30% ** 2.7%
Pediconi et al 2007 164 4.2% 2.4% 29.0%
Mameri et al 2008 99 18.0% 0.7% 3.0%
Duygulu et al 2012 68 5.8% 4.4% 1.4%
Afzal et al ~ 2015 49 12% ** 10.0%
**: Authors did not demarcate between multifocal and multi centeric lesions; ~: Current study reports results
Table 1. Diagnostic Performance of MRI Breast for Evaluation of Multifocal/Multicenteric & Contralateral 
Lesions
Type of Lesion Sensitivity Specificity * PPV $NPV Accuracy
 (95% CI§) (95% CI§) (95% CI§) (95% CI§) 
Multifocal / Multicentric lession 85.71% (0.42-0.99) 88.88% (0.73-0.96) 60% (0.27-0.86) 96.96% (0.82-0.99) 88.37%
Contralateral Breast 100% (0.46-1¶) 97.73% (0.86-0.99 ) 83.33% (0.36-0.99) 100% (0.89-1¶) 97.96%
§ 95% CI: 95% confidence interval; * PPV: Positive Predicative Value; $ NPV: Negative Predictive Value; (¶): CI insignificant as one of the cell 
contains a “zero value”
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index breast lesions was infiltrating ductal carcinoma 
61% followed by infiltrating lobular carcinoma in 22%. 
The others were papillary carcinoma, mucinous carcinoma 
and DCIS. 
On the basis of MRI scan, suspicious findings detected 
in the contralateral breast were confirmed to be malignant 
in five patients; this comprised the true positive group. 
Out of these two were invasive lobular carcinoma (ILC) 
and one each of invasive ductal carcinoma (IDC), ductal 
carcinoma in situ (DCIS) and papillary carcinoma. The 
size of the index lesion in this group ranged from 1 to 5 
cm. The size of the lesion in contralateral breast detected 
on MRI was below 1.0 cm and no axillary lymph node 
involvement was present.
The false positive MRI of contralateral breast on 
histopathology was diagnosed as florid ductal hyperplasia, 
papilloma, apocrine metaplasia, adenosis and fibrocystic 
change.
The diagnostic performance of breast MRI for 
detection of lesions in contralateral breast and in the 
ipsilateral breast in the present study as shown in Table 1.
Discussion
Breast MRI is an expensive test, reported to have high 
sensitivity (94-100%) but low specificity that ranges from 
37-97% (Orel and Schnall, 2001). These factors restricts 
its usage as a screening modality for the population and 
hence it is utilized for limited indications like women with 
genetic predisposition, strong family history /personal 
history of breast cancer, women with lobular carcinoma 
or atypia, etc (Tilanus-Linthorst et al., 2000). Analysis of 
the MRI detected enhancing lesions in accordance to the 
American college of Radiology breast imaging reporting 
and data system (BIRADS) lexicon is an essential factor 
in improving the diagnostic performance. (Abdulkareem, 
2014).
In this retrospective study we evaluated the diagnostic 
performance of breast MRI in the detection of an otherwise 
occult contra lateral breast cancer in addition to multifocal 
/multicenteric lesions (Table 1). Additional cancer foci 
that are histologically proven are reported in 21 to 63 % 
of women with clinical diagnosis of localized cancer and 
further confirmed by imaging (Houssami et al., 2008) 
In this study cancer was detected in contralateral breast 
in patients with diagnosed breast cancer in 10 % which 
is in line with the various published reports in literature 
(3% - 24%) (Lehman et al., 2007) In Asian population 
however synchronous bilateral cancer ranges from 1.5 -2% 
(Kim et al., 2012) which is much lower than our study. 
The detection rate of multifocal /multicenteric lesions 
in the present study is 12% and is in the range as stated 
in previous studies i.e. 2.4 to 30 % (Berg et al., 2004; 
Pediconi et al., 2007) (Table 2)
The breast cancer screening programme is non-existent 
in our country and majority of patients present with 
palpable tumors as is also evident in our study. In our 
study 78% of our patients, the index lesion at the time of 
presentation was in the range of 1 to 5 cm. Increase size 
of index tumor is identified as a correlate for the increased 
frequency of additional malignant foci in ipsilateral and 
contralateral breast. (Moon et al., 2002)
In the present study the index and the contralateral 
lesions showed similar histology in 80 % cases. (Liberman 
et al., 2003) reports concordant histology in 67% of 
women. Early age at initial diagnosis, family history 
of breast cancer and a lobular histology have been 
identified as risk factors associated with development 
of contralateral breast cancer in women with a known 
primary of breast. The two risk factors i.e. early age 
at diagnosis and lobular histology is also noted in our 
patients with synchronous bilateral breast cancer. (Chen 
et al.,1999; Ji and Hemminki, 2007) 
An important risk factor associated with breast cancer 
is the mammographic density, the principal mechanism 
likely to be masking rather than rapid tumor growth (Wang 
et al., 2012). In such cases alternative imaging techniques 
are likely to enhance detection of occult / additional cancer 
(Boyd et al., 2007).
The specificity of MRI in the evaluation of contralateral 
breast in our study is 97.7% and is at the higher side of 
that reported in literature (37-97%). (Orel and Schnall , 
2001) The proposed reason for this is because sonographic 
correlate was found in 62 % of the lesions detected on MRI. 
The results are similar to the study by Kim et al which 
reports detection of ultrasound correlates in 64% and out 
of these 69% of lesions characterized as masses and 46% 
as non-mass like enhancement on MRI (Demartini et al., 
2009) In the present study none of the enhancing foci 
less than 5 mm had any ultrasound correlate on second 
look ultrasound and in the absence of any correlate, 
MRI was categorized as probably benign finding. All of 
these patients were stable on follow-up imaging without 
development of interval malignancy hence confirming 
the benign nature of the enhancing foci. (Figure 1). In 
keeping with multiple previous studies (Candelaria and 
Fornage, 2011), more malignant lesions showed a second 
look ultrasound correlate than benign lesions. (Figure 2 
and 3) Based on the previous reports (Beran et al., 2005) 
describing the lower probability of malignancy in MRI 
detected lesions which are occult on ultrasound some sites 
Figure 3. Dynamic Contrast Enhanced MRI Showing 
Index Lesion in Right Breast. Suspicious lesion with rapid 
enhancement and early washout on left side. On second look 
ultrasound revealed ill defined hypoechoic lesion which on 
subsequent biopsy was diagnosed as infiltrating ductal carcinoma 
and confirmed presence of malignancy in contralateral breast
Asian Pacific Journal of Cancer Prevention, Vol 16, 2015 7611
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also recommend short term imaging follow up. 
Breast MRI although being highly sensitive but false 
negative findings do occur, mostly due to lack of apparent 
mass as seen with DCIS and lobular carcinoma(Hillman 
et al., 2012). The false negative cases mostly result from 
lack of enhancement of lesions or misinterpretation of 
enhancing lesion. (Millet et al., 2012). In the present 
study lack of enhancement of lesion being the cause of 
false negative in the evaluation of multicenteric/multifocal 
disease. There was no false negative case in the MRI 
screening of contralateral breast in the present study 
which is also confirmed by stability of the findings on 
follow up imaging. 
The sensitivity and NPV of MRI in the screening of 
contralateral breast for synchronous lesions is 100% in 
the present study. This information questions the value of 
contralateral prophylactic mastectomies (Herrinton et al., 
2005) and is expected to influence the decision making 
by women and breast surgeons regarding the surgical 
options. In addition it also results in lower rate of cancer 
recurrence at follow up.
In comparison to contralateral breast, more false 
positive cases were identified in the ipsilateral breast. 
Our sample size is small and further studies with large 
sample size are needed to explain this biological behavior 
and micro environmental influences (Cichon et al,. 2010; 
Yang et al., 2010).
 Several limitations of the study were identified, One 
of these being small sample size and retrospective design. 
The non-availability of MRI guided biopsy instruments 
also added to the limitation of the study. But in the present 
study, second look ultrasound was performed for all MRI 
detected lesions by radiologist interpreting the MRI 
with more than 5 years of experience in breast imaging. 
Pathological confirmation for all the lesions could not be 
obtained due to reason described above, but follow-up 
imaging ranging from 2 to 5 years was available to confirm 
the benign nature of MRI detected findings without an 
ultrasound correlate. In the present study the impact of 
diagnosing additional malignant foci on the treatment and 
survival of patient are not evaluated. 
Our study highlights the diagnostic performance and 
the added value of contrast enhanced breast MRI in the 
detection of multifocal /multicenteric and contralateral 
malignant lesions. In patients with diagnosed breast cancer 
showing dense breast parenchyma on mammography and 
with infiltrating lobular carcinoma as index lesion MRI 
is particularly useful with excellent negative predictive 
value in the exclusion of additional malignant foci in the 
ipsilateral and contralateral breast.
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